shutterstock_585122686 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Nektar and Alkermes data could translate into a resurgence of IL-2 agonists

Data for modified IL-2 selective receptor agonists, NKTR-214 and ALKS 4230, was presented at the 2019 Society for Immunotherapy of Cancer (SITC) conference.